Please upgrade your browser.
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
CELLDEX THERAPEUTICS INC Symbol U : CLDX Recent Sedar Documents Celldex Therapeutics' CDX-1127 Well Tolerated and Demonstrates Anti-Tumor Activity
Very favorable safety profile; no evidence of immune related toxicities; three patients with significant tumor shrinkage...
Virginia Beach was notified by their insurance provider that their plan no longer qualified under Obamacare’s regulations.
Pastor Joey Butler, the beloved Blue Springs minister whose faith inspired thousands, has died at age 51. Suffering with renal cell cancer...
"They don't want a cure."
A new and independent analysis of Obamacare warns of a ticking time bomb...
A clinical, radiologic, and pathologic study of 34 cases.
Nivolumab is an investigational compound being studied as a potential treatment option for lung cancer, renal cell carcinoma (kidney cancer), and melanoma.
An Underappreciated Form of Hereditary Kidney Cancer
Scotland has become the first part of the UK to approve two new cancer drugs for routine use in the NHS
|Powered by NeonCRM|